ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 198 filers reported holding ACORDA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $446,000 | -89.1% | 15,543 | -91.0% | 0.12% | -78.5% |
| Q1 2018 | $4,078,000 | -2.9% | 172,443 | -11.9% | 0.57% | +12.5% |
| Q4 2017 | $4,199,000 | -25.3% | 195,743 | -17.6% | 0.50% | -17.6% |
| Q3 2017 | $5,618,000 | +31.0% | 237,543 | +9.2% | 0.61% | +17.4% |
| Q2 2017 | $4,287,000 | +61.2% | 217,610 | +71.9% | 0.52% | +59.6% |
| Q1 2017 | $2,659,000 | +55.0% | 126,599 | +38.8% | 0.33% | +7.6% |
| Q4 2016 | $1,715,000 | +93.6% | 91,199 | +115.0% | 0.30% | +46.2% |
| Q3 2016 | $886,000 | +68.1% | 42,413 | +105.3% | 0.21% | +57.6% |
| Q2 2016 | $527,000 | +0.8% | 20,663 | +4.6% | 0.13% | -21.9% |
| Q1 2016 | $523,000 | – | 19,763 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |